-
Je něco špatně v tomto záznamu ?
Nanotechnology - new trends in the treatment of brain tumours
P. Krůpa, S. Řehák, D. Diaz-Garcia, S. Filip
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Digitální knihovna NLK
Plný text - Článek
Číslo
Ročník
Zdroj
Zdroj
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2012-06-01
ROAD: Directory of Open Access Scholarly Resources
od 1997
- MeSH
- antitumorózní látky terapeutické užití MeSH
- diagnostické zobrazování MeSH
- genetická terapie MeSH
- genetické vektory MeSH
- lidé MeSH
- nádory mozku terapie MeSH
- nanočástice terapeutické užití MeSH
- nanotechnologie trendy MeSH
- nanotrubičky MeSH
- nosiče léků MeSH
- systémy cílené aplikace léků MeSH
- transplantace kmenových buněk MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
High grade gliomas are some of the deadliest human tumours. Conventional treatments such as surgery, radiotherapy and chemotherapy have only a limited effect. Nowadays, resection is the common treatment of choice and although new approaches, such as perioperative magnetic resonance imaging or fluorescent microscopy have been developed, the survival rate of diagnosed patients is still very low. The inefficacy of conventional methods has led to the development of new strategies and the significant progress of nanotechnology in recent years. These platforms can be used either as novel imaging tools or to improve anticancer drug delivery into tumours while minimizing its distribution and toxicity in healthy tissues. Amongst the new nanotechnology platforms used for delivery into the brain tissue are: polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles and nucleic acid based nanoparticles (DNA, RNA interference [RNAi] and antisense oligonucleotides [ASO]). These nanoparticles have been applied in the delivery of small molecular weight drugs as well as macromolecules - proteins, peptides and genes. The unique properties of these nanoparticles, such as surface charge, particle size, composition and ability to modify their surface with tissue recognition ligands and antibodies, improve their biodistribution and pharmacokinetics. All of the above mentioned characteristics make of nanoplatforms a very suitable tool for its use in targeted, personalized medicine, where they could possibly carry large doses of therapeutic agents specifically into malignant cells while avoiding healthy cells. This review poses new possibilities in the large field of nanotechnology with special interest in the treatment of high grade brain tumours.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15030955
- 003
- CZ-PrNML
- 005
- 20190118100625.0
- 007
- ta
- 008
- 151001s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2015.79 $2 doi
- 035 __
- $a (PubMed)25938897
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Krůpa, Petr, $d 1987- $7 xx0231389 $u Charles University in Prague, Department of Neurosurgery, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic
- 245 10
- $a Nanotechnology - new trends in the treatment of brain tumours / $c P. Krůpa, S. Řehák, D. Diaz-Garcia, S. Filip
- 520 9_
- $a High grade gliomas are some of the deadliest human tumours. Conventional treatments such as surgery, radiotherapy and chemotherapy have only a limited effect. Nowadays, resection is the common treatment of choice and although new approaches, such as perioperative magnetic resonance imaging or fluorescent microscopy have been developed, the survival rate of diagnosed patients is still very low. The inefficacy of conventional methods has led to the development of new strategies and the significant progress of nanotechnology in recent years. These platforms can be used either as novel imaging tools or to improve anticancer drug delivery into tumours while minimizing its distribution and toxicity in healthy tissues. Amongst the new nanotechnology platforms used for delivery into the brain tissue are: polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles and nucleic acid based nanoparticles (DNA, RNA interference [RNAi] and antisense oligonucleotides [ASO]). These nanoparticles have been applied in the delivery of small molecular weight drugs as well as macromolecules - proteins, peptides and genes. The unique properties of these nanoparticles, such as surface charge, particle size, composition and ability to modify their surface with tissue recognition ligands and antibodies, improve their biodistribution and pharmacokinetics. All of the above mentioned characteristics make of nanoplatforms a very suitable tool for its use in targeted, personalized medicine, where they could possibly carry large doses of therapeutic agents specifically into malignant cells while avoiding healthy cells. This review poses new possibilities in the large field of nanotechnology with special interest in the treatment of high grade brain tumours.
- 650 _2
- $a antitumorózní látky $x terapeutické užití $7 D000970
- 650 _2
- $a nádory mozku $x terapie $7 D001932
- 650 _2
- $a diagnostické zobrazování $7 D003952
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a systémy cílené aplikace léků $7 D016503
- 650 _2
- $a genetická terapie $7 D015316
- 650 _2
- $a genetické vektory $7 D005822
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nanočástice $x terapeutické užití $7 D053758
- 650 _2
- $a nanotechnologie $x trendy $7 D036103
- 650 _2
- $a nanotrubičky $7 D043942
- 650 _2
- $a transplantace kmenových buněk $7 D033581
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Řehák, Svatopluk $u Charles University in Prague, Department of Neurosurgery, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic
- 700 1_
- $a Díaz Garcia, Daniel $u Charles University in Prague, Department of Histology and Embryology, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic $7 xx0318858
- 700 1_
- $a Filip, Stanislav, $u Charles University in Prague, Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Czech Republic $d 1961- $7 jn20010309153
- 773 0_
- $w MED00010947 $t Acta medica (Hradec Králové) Universitas Carolina, Facultas Medica Hradec Králové $x 1211-4286 $g Roč. 57, č. 4 (2014), s. 142-150
- 856 41
- $u https://actamedica.lfhk.cuni.cz/media/pdf/am_2014057040142.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y 4 $z 0
- 990 __
- $a 20151001 $b ABA008
- 991 __
- $a 20190118100840 $b ABA008
- 999 __
- $a ok $b bmc $g 1094790 $s 914071
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 57 $c 4 $d 142-150 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
- LZP __
- $b NLK118 $a Pubmed-20151001